Larvol Delta - Bristol-Myers-Squibband-Ono-Pharmaceuticalhave-sued-Amgenin-Delaware-federal-court-seeking-to-block-Amgen39s-proposed-US-biosimilar-of-their-blockbuster-cancer-immunotherapy-drug-Opdivo

Blincyto (blinatumomab) - Amgen

blinatumomab subcutaneous - Amgen

http://clinicaltrials.gov/ct2/show/NCT07223190

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next